维普中文期刊产品整合服务
68篇 您的检索式:作者名="SAMAMA M M"
    题名 作者 年代 出处 被引量
1Massive transfusion: an overview of themain characteristics and potential risks associated with substances used forcorrection of a coagulopathy显示文摘Seghatchian J Samama M M 2012Transfus Apher Sci2012,47,2:1
2New antithrombotic drugs:american college of chest physicians evidence-based clinical practice guidelines (8th ed)显示文摘Weitz J I Hirsh J Samama M M 2008Chest2008,133,6:1
3In vitro effect on heptest of low molecular weight heparn显示文摘Bara L Mardiguian J Samama M 1990Thromb Res1990,57,:1
4Vaginal keratinization during the esrous cycle in rats:a model f or evaluating retinoid activity显示文摘Chateau D Geiger J M Samama B 1996Skin Pharmacol1996,,9:1
5A comparative study of recombinant hirudin and standard hEParin in the wessler model 显示文摘BARAL BLOCH M F SAMAMA M M 1992Thromb Res1992,68,2:1
6New Antithrombotic Drugs:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘Weitz J I Eikelboom J W Samama M M 2012Chest2012,141,2:1
7Biochemistry and clinical pharmacology of new anticoagulant agents 显示文摘Samama M M Gerotziafas G T 2000Clin Lab News2000,26,:1
8Ultrastructure of a model of thrombogenesis induced by mechanical injury显示文摘Le Menn R Bara L Samama M 1981J Submicrosc Cytol1981,13,4:1
9Extended venous thromboembolism prophylaxis after total hip replace- ment:a comparison of low-molecular-weight-heparin with oral anticoagulant显示文摘Samama CM Vray M Barre J 2002Arch Intern Med2002,162,19:1
10D-dimer levels,constitutional thrombophilila,and venous thrombosis prediction:clinical aspects and implications显示文摘Samama M M Horellou M H Elalamyl 2005Semin Vase Med2005,5,4:1
11In vitro effect on Heptest of low molecular weight heparin fractions and preparations with various anti-Iia and anti-Xa activities显示文摘Bara L Mardiguian J Samama M 1990Thromb Res1990,57,5:1
12Extended ve- nous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant 显示文摘Samama CM Vray M Barre J 2002Arch Intern Med2002,162,19:1
13Pharmacokinetics of low molecular weight heparins显示文摘Bara L Samama M 1988Acta Chir Scand Suppl1988,543,:1
14Massive transfusion and coagulopathy: pathophysiology and implications for clinical management 显示文摘HARDY J F DE MOERLOOSE P SAMAMA M 2004Can J Anaesth2004,51,4:1
15Crystal structure of an Acylation Transition-state Analogy of the TEM-1 β-lactamases mechanismstic implications for class A β-lactamases 显示文摘 Pratt RF Samama JP 1998Biochemistry1998,37,:1
16Massive transfusion and coagulopathy: pathophysiology and implications for clinical management显示文摘Hardy JF De Moerloose P Samama M 2004Can J Anaesth2004,51,4:1
17New antithrombotic drugs: American College of Chest Physician Evdience- Based Clinical Practice Guidelines (8th Edition)显示文摘Weitz J I Hirsh J Samama M M 2008Chest2008,133,6:1
18New antithrombotic drugs:American college of chest physicians evidence-based clinical practice guidelines (8th Edition)显示文摘Weitz J I Hirsh J Samama M M 2008Chest2008,,:1
19Clinical and laboratory evaluation of hospitalized patients with severe ovarian hyperstimulation syndrome显示文摘Sabino J Filho C Samama M 2003Reproductive Biomedicine Online2003,6,:1
20Familial dysfibrinogenemia and thrombophilia:Report on a study of the SSC Subcommittee on Fibrinogen显示文摘Haverkate F Samama M 1995Thromb Haemost1995,73,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费